第 1 到 31 筆結果,共 31 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time | Lee, Chih-Ying; WEN-FANG CHENG ; PO-HAN LIN ; YU-LI CHEN ; Huang, Shih-Han; Lei, Kai-Hang; Chang, Ko-Yu; Ko, Min-Yu; HUNG-YUAN CHI | Cell reports. Medicine | 0 | 0 | |
2 | 2023 | Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome | PO-HAN LIN ; YU-WEN TIEN ; WEN-FANG CHENG ; YING-CHENG CHIANG ; Wu, Chien-Huei; Yang, Karen; CHIUN-SHENG HUANG | Journal of Gynecologic Oncology | 0 | ||
3 | 2023 | Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single-country, multi-center, patient-reported outcome study | Kuo, Wen-Ling; PO-HAN LIN ; Peng, Meng-Ting; Chu, Chia-Hui; Cho, Chia-Wei | Journal of Genetic Counseling | |||
4 | 2022 | Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders | PO-HAN LIN ; Tseng, Ling-Ming; Lee, Yi-Hsuan; Chen, Shou-Tung; Yeh, Dah-Cherng; Dai, Ming-Shen; Liu, Liang-Chih; MING-YANG WANG ; Chiao Lo ; Chang, Stanley; Tan, Kien Thiam; Chen, Shu-Jen; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Journal of the Formosan Medical Association | 6 | 4 | |
5 | 2022 | Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients | PO-HAN LIN ; Chen, Shin-Cheh; Tseng, Ling-Ming; KING-JEN CHANG ; Huang, Ai-Chu; Cheng, Kuo-Chih; Yang, Karen; Wu, Hui-Chen; Chao, Tsu-Yi; Chang, Yuan-Ching; Lin, Peng-Chan; WEN-HUNG KUO ; Kuo, Wen-Lin; CHING-HUNG LIN ; Chen, Huo-Mu; Yeh, Dah-Cherng; Liu, Liang-Chih; Liu, Chun-Yu; MING-YANG WANG ; Chiao Lo ; YEN-SHEN LU ; CHIUN-SHENG HUANG | Breast cancer research and treatment | 5 | 4 | |
6 | 2021 | A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes | YING-CHENG CHIANG ; PO-HAN LIN ; TZU-PIN LU ; KUAN-TING KUO ; YI-JOU TAI ; HENG-CHENG HSU ; CHIA-YING WU ; Lee, Chia-Yi; Shen, Hung; CHI-AN CHEN ; WEN-FANG CHENG | Biomedicines | 3 | 3 | |
7 | 2021 | Reproductive and environmental exposures and the breast cancer risk in Taiwanese women | Wu, Hui-Chen; Yang, Hwai-I; PO-HAN LIN ; Chen, Chien-Jen; Santella, Regina M; Terry, Mary Beth | Scientific Reports | 4 | 3 | |
8 | 2021 | Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction | YING-CHENG CHIANG ; PO-HAN LIN ; WEN-FANG CHENG | Frontiers in Oncology | 14 | 13 | |
9 | 2021 | Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy | PO-HAN LIN ; MING-YANG WANG ; Chiao Lo ; LI-WEI TSAI ; Yen, Tzu-Chun; Huang, Thomas Yoyan; Huang, Wei-Chih; Yang, Karen; Chen, Chih-Kai; Fan, Sheng-Chih; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Frontiers in Oncology | 14 | 11 | |
10 | 2020 | Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer | PO-HAN LIN ; MING CHEN; TSAI, LI-WEI ; Chiao Lo ; Yen, Tzu-Chun; Huang, Thomas Yoyan; Chen, Chih-Kai; Fan, Sheng-Chih; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Cancer science | 30 | 25 | |
11 | 2019 | Varlitinib downregulates HER/ERK signaling and induces apoptosis in triple negative breast cancer cells | Liu C.-Y.; Chu P.-Y.; Huang C.-T.; Chen J.-L.; Yang H.-P.; Wang W.-L.; Lau K.-Y.; Lee C.-H.; Lan T.-Y.; Huang T.-T.; PO-HAN LIN ; Dai M.-S.; Tseng L.-M. | Cancers | 23 | 22 | |
12 | 2018 | Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels | Kwong A.; Ho J.C.W.; Shin V.Y.; Kurian A.W.; Tai E.; Esserman L.J.; Weitzel J.N.; PO-HAN LIN ; Field M.; Domchek S.M.; Lo J.; Ngan H.Y.S.; Ma E.S.K.; Chan T.L.; Ford J.M. | Oncotarget | 7 | 0 | |
13 | 2017 | A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice | PO-HAN LIN ; Li H.-Y.; Fan S.-C.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T.; YEN-HSUAN NI ; Chiu C.-F. | Cancer Medicine | 47 | 41 | |
14 | 2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 35 | 30 | |
15 | 2017 | Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells | Liu C.-Y.; Lau K.-Y.; Hsu C.-C.; Chen J.-L.; Lee C.-H.; Huang T.-T.; Chen Y.-T.; Huang C.-T.; PO-HAN LIN ; Tseng L.-M. | PLoS ONE | 45 | 40 | |
16 | 2016 | Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer | PO-HAN LIN ; WEN-HUNG KUO ; Huang A.-C.; YEN-SHEN LU ; CHING-HUNG LIN ; SUNG-HSIN KUO ; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; SUNG-LIANG YU ; KING-JEN CHANG ; PEI-LUNG CHEN ; YEN-HSUAN NI ; CHIUN-SHENG HUANG | Oncotarget | 74 | 64 | |
17 | 2016 | Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors | Chou, Wen-Chi; PO-HAN LIN ; Yeh, Yi-Chen; Shyr, Yi-Ming; Fang, Wen-Liang; Wang, Shin-E.; Liu, Chun-Yu; Chang, Peter Mu-Hsin; Chen, Ming-Han; Hung, Yi-Ping; Li, Chung-Pin; Chao, Yee; YI-PING HUNG | International Journal of Biological Sciences | 28 | 26 | |
18 | 2014 | Safety and efficacy of pegylated liposomal doxorubicinbased adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer | Lien M.-Y.; Liu L.-C.; Wang H.-C.; Yeh M.-H.; Chen C.-J.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Li L.-Y.; PO-HAN LIN ; Chiu C.-F. | Anticancer Research | 30 | 30 | |
19 | 2014 | Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation | Yeh S.-P.; Lo W.-C.; Hsieh C.-Y.; Bai L.-Y.; Lin C.-C.; PO-HAN LIN ; Lin C.-Y.; Liao Y.-M.; Chiu C.-F. | Supportive Care in Cancer | 8 | 3 | |
20 | 2013 | Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy | PO-HAN LIN ; Yeh M.-H.; Liu L.-C.; Chen C.-J.; Tsui Y.-C.; Su C.-H.; Wang H.-C.; Liang J.-A.; Chang H.-W.; Wu H.-S.; Yeh S.-P.; Li L.-Y.; Chiu C.-F. | Journal of Surgical Oncology | 13 | 12 | |
21 | 2013 | Prognostic analysis of adjuvant chemotherapy in patients with nasopharyngeal carcinoma | Lin C.-C.; Chen T.-T.; Lin C.-Y.; Hsieh C.-Y.; PO-HAN LIN ; Chien C.-R.; Chiu C.-F.; Yeh S.-P. | Future Oncology | 6 | 5 | |
22 | 2013 | OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis | Bai L.-Y.; Weng J.-R.; Chiu C.-F.; Wu C.-Y.; Yeh S.-P.; Sargeant A.M.; PO-HAN LIN ; Liao Y.-M. | Biochemical Pharmacology | 27 | 27 | |
23 | 2013 | Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3 | PO-HAN LIN ; Lin C.-C.; Yang H.-I.; Li L.-Y.; Bai L.-Y.; Chiu C.-F.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-Y.; Ho C.-M.; Yang S.-F.; Peng C.-T.; Tsai F.-J.; Yeh S.-P. | Leukemia Research | 34 | 31 | |
24 | 2012 | Novel heterozygous tissue-nonspecific alkaline phosphatase (TNAP) gene mutations causing lethal perinatal hypophosphatasia | KAI-CHI CHANG ; PO-HAN LIN ; Su Y.-N.; STEVEN SHINN-FORNG PENG ; NI-CHUNG LEE ; HUNG-CHIEH CHOU ; CHIEN-YI CHEN ; Hsieh W.-S.; PO-NIEN TSAO | Journal of Bone and Mineral Metabolism | 14 | 12 | |
25 | 2012 | Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer | Lin C.-Y.; Ho C.-M.; Bau D.-T.; Yang S.-F.; Liu S.-H.; PO-HAN LIN ; Lin T.-H.; Tien N.; Shih M.-C.; Lu J.-J. | Anticancer Research | 13 | 13 | |
26 | 2012 | Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer | WEN-HUNG KUO ; PO-HAN LIN ; Huang A.-C.; YIN-HSIU CHIEN ; Liu T.-P.; YEN-SHEN LU ; Bai L.-Y.; Sargeant A.M.; CHING-HUNG LIN ; ANN-LII CHENG ; FON-JOU HSIEH ; WUH-LIANG HWU ; KING-JEN CHANG | Journal of Human Genetics | 19 | 19 | |
27 | 2011 | Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? | CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; KUAN-TING KUO ; Wang C.-C.; You S.-L.; PO-HAN LIN ; DWANG-YING CHANG ; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG | Journal of Clinical Pathology | 8 | 8 | |
28 | 2011 | Cisplatin as an active treatment in zoledronate-refractory hypercalcemia | PO-HAN LIN ; Chiu C.-F.; YEN-SHEN LU | Annals of Oncology | 1 | 1 | |
29 | 2010 | Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation | PO-HAN LIN ; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 6 | 4 | |
30 | 2008 | Acute Q fever presenting as fever of unknown origin with rapidly progressive hepatic failure in a patient with alcoholism | PO-HAN LIN ; Lo, Yi Chun; FU-TIEN CHIANG ; Wang, Jiun Ling; YUNG-MING JENG ; CHI-TAI FANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association | 6 | 5 | |
31 | 2003 | Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation | PO-HAN LIN ; Lee, Shih Huang; Su, Chia Ping; Wei, Yau Huei | Free Radical Biology & Medicine | 108 | 109 |